Related Experiment Videos
Restenosis: Intracoronary Brachytherapy
Douglas E. Drachman1, Daniel I. Simon
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. dsimon@rics.bwh.harvard.edu
Current Treatment Options in Cardiovascular Medicine
|February 23, 2002
Summary
Intracoronary radiation (brachytherapy) effectively treats in-stent restenosis after coronary interventions, reducing re-narrowing and repeat procedures. However, it increases late stent thrombosis risk, necessitating careful patient selection and extended antiplatelet therapy.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Physics
Background:
- In-stent restenosis is a major limitation following percutaneous coronary intervention for symptomatic coronary artery disease.
- Conventional treatments for in-stent restenosis have limited success rates (50-80%).
Purpose of the Study:
- To evaluate the efficacy and safety of intracoronary radiation (brachytherapy) for treating in-stent restenosis.
- To identify patient subgroups who may benefit most from brachytherapy.
Main Methods:
- Intracoronary brachytherapy targets cellular proliferation in the neointima causing in-stent restenosis.
- Clinical trials assessed angiographic restenosis and target vessel revascularization rates.
Main Results:
- Brachytherapy reduced angiographic restenosis by 50-60% and target vessel revascularization by 40-50%.
- Benefits were notable in patients with diabetes, long lesions, or saphenous vein bypass graft lesions.
- An increased risk of late stent thrombosis and need for prolonged antiplatelet therapy were observed.
Conclusions:
- Intracoronary brachytherapy is an effective treatment for in-stent restenosis, particularly in specific patient groups.
- The evolving role of brachytherapy must consider advances in drug-eluting stents for restenosis prevention.